ES2689371B1 - Procedimiento para la preparación de pamoato de pirvinio y sus formas cristalinas - Google Patents

Procedimiento para la preparación de pamoato de pirvinio y sus formas cristalinas Download PDF

Info

Publication number
ES2689371B1
ES2689371B1 ES201700479A ES201700479A ES2689371B1 ES 2689371 B1 ES2689371 B1 ES 2689371B1 ES 201700479 A ES201700479 A ES 201700479A ES 201700479 A ES201700479 A ES 201700479A ES 2689371 B1 ES2689371 B1 ES 2689371B1
Authority
ES
Spain
Prior art keywords
procedure
preparation
crystalline forms
pyrvinium pamoate
pyrvinium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201700479A
Other languages
English (en)
Spanish (es)
Other versions
ES2689371A8 (es
ES2689371A1 (es
Inventor
Rio Pericacho Jose Luis Del
Via Josep Marti
Paredes Antonio De Padua Canovas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Urquima SA
Original Assignee
Urquima SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urquima SA filed Critical Urquima SA
Publication of ES2689371A1 publication Critical patent/ES2689371A1/es
Publication of ES2689371A8 publication Critical patent/ES2689371A8/es
Application granted granted Critical
Publication of ES2689371B1 publication Critical patent/ES2689371B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES201700479A 2016-04-13 2017-03-29 Procedimiento para la preparación de pamoato de pirvinio y sus formas cristalinas Expired - Fee Related ES2689371B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382169.7A EP3231796A1 (en) 2016-04-13 2016-04-13 A process for the preparation of pyrvinium pamoate and crystalline forms thereof
EP16382169.7 2017-02-28

Publications (3)

Publication Number Publication Date
ES2689371A1 ES2689371A1 (es) 2018-11-13
ES2689371A8 ES2689371A8 (es) 2018-12-05
ES2689371B1 true ES2689371B1 (es) 2019-08-22

Family

ID=55809063

Family Applications (2)

Application Number Title Priority Date Filing Date
ES201700479A Expired - Fee Related ES2689371B1 (es) 2016-04-13 2017-03-29 Procedimiento para la preparación de pamoato de pirvinio y sus formas cristalinas
ES17717678T Active ES2977432T3 (es) 2016-04-13 2017-04-12 Procedimiento para la preparación de pamoato de pirvinio y sus formas cristalinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES17717678T Active ES2977432T3 (es) 2016-04-13 2017-04-12 Procedimiento para la preparación de pamoato de pirvinio y sus formas cristalinas

Country Status (5)

Country Link
EP (2) EP3231796A1 (enExample)
JP (1) JP7021107B2 (enExample)
ES (2) ES2689371B1 (enExample)
FI (1) FI3442956T3 (enExample)
WO (1) WO2017178524A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12447147B2 (en) 2019-10-22 2025-10-21 Thomas Jefferson University Methods of treating, ameliorating, and/or preventing cancer using pyrvinium compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2515912A (en) * 1946-10-01 1950-07-18 Eastman Kodak Co Pyrrole dimethinecyanine dyes
BE572031A (enExample) 1957-11-06
EP1841428A1 (en) 2005-01-18 2007-10-10 Immusol Incorporated Novel quinolinium salts and derivatives

Also Published As

Publication number Publication date
EP3442956B1 (en) 2024-03-27
WO2017178524A1 (en) 2017-10-19
BR112018071009A2 (pt) 2019-02-12
JP7021107B2 (ja) 2022-02-16
EP3442956A1 (en) 2019-02-20
FI3442956T3 (fi) 2024-05-03
JP2019511523A (ja) 2019-04-25
ES2977432T3 (es) 2024-08-23
EP3231796A1 (en) 2017-10-18
ES2689371A8 (es) 2018-12-05
ES2689371A1 (es) 2018-11-13

Similar Documents

Publication Publication Date Title
IL264143B (en) Processes for preparing olaparib
PT3368534T (pt) Ditosilato de valbenazina e polimorfos do mesmo
EP3389490A4 (en) IMU CALIBRATION
DK3668851T3 (da) Fremgangsmåde til fremstilling af thiocarbonater
DK3458053T3 (da) Anvendelse af riluzol, riluzolprodrugs eller riluzolanaloger med immunterapier til cancerbehandling
ES2796903T8 (es) Procedimiento de uso de inmunoconjugados anti-CD79b
DK3294720T3 (da) Fremgangsmåde til fremstilling af terpinolenepoxid
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3503890T3 (da) Anvendelse af pridopidin til behandling af dystonier
ES2710313R1 (es) Composicion para la prevencion de la trombogenesis y procedimiento para fabricacion de la misma
EP3406336A4 (en) NANO FOIL OF CORE CASE STRUCTURE TYPE
IL282114A (en) Processes for preparing functionalized cyclooctenes
ES2837136R1 (es) Proceso para la preparación de 3alfa-hidroxi-5alfa-pregnan-20-ona (Brexanolona)
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3436074T3 (da) Thiazolidforbindelser til behandling af virale infektioner
DK3464013T3 (da) Forbindelse mellem konstruktionsdele med forskellige varmeudvidelseskoefficienter
EP3535230A4 (en) IMPROVED PERFORMANCE OF TECHNICAL CERAMICS
BR112017026560A2 (pt) processo para preparação de apremilast e seus intermediários.
LT3519394T (lt) Kalkobutrolio modifikacijos kristalinės formos gavimo būdas
DK3251523T3 (da) Fremgangsmåde til fremstilling af granuleret tilskudsfoder
DK3442944T3 (da) Fremgangsmåde til fremstillingen af 4-aminoindanderivater og relaterede aminoindanamider
EP3442041A4 (en) BIMORPHE PIEZOELECTRIC LAYER
DK3430004T3 (da) Faststofformer af nilotinibsalte
PL3630725T3 (pl) Postać krystaliczna n-butylodeoksygalaktonojirymycyny
HUE055374T2 (hu) Eljárás Lenvatinib elõállítására

Legal Events

Date Code Title Description
BA2A Patent application published

Ref document number: 2689371

Country of ref document: ES

Kind code of ref document: A1

Effective date: 20181113

FG2A Definitive protection

Ref document number: 2689371

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20190822

FD2A Announcement of lapse in spain

Effective date: 20260424